While FL has been associated with various genetic polymorphisms, several studies have highlighted the roles of PNPLA3, SAMM50, NCAN, GCKR, and LEP in susceptibility to NAFLD [53–56]. The gene discussed is FLT3LG; the disease is metabolic dysfunction-associated steatotic liver disease.